Here is a look at some of the top health and medicine stories making headlines today: CANCELLED INTERNSHIP…
Novo Nordisk has announced that it will be offering its obesity drug Wegovy directly to patients at a…
The rise of infectious diseases in pets is becoming a growing concern, mirroring the increase in human diseases.…
New Delhi: Leading biotechnology company Biocon has recently introduced a groundbreaking product in the UK for managing diabetes…
Eli Lilly's next-generation obesity drug, known as retatrutide, is causing unexpected outcomes in ongoing trials. Instead of struggling…
The ongoing debate surrounding the use of compounded weight loss drugs as a more affordable alternative to branded…
A group of 58 researchers have challenged the traditional definition and diagnosis of obesity, arguing that current methods…
Measuring body fat more carefully could help treat obesityHalfpoint/Getty Images Rethinking the way we define obesity could have…
Shifting the focus away from BMI as the sole indicator of obesity opens up a new realm of…
The introduction of the anti-obesity drug Zepbound by Eli Lilly & Co. is projected to have a significant…
The Food and Drug Administration (FDA) recently approved Eli Lilly's obesity drug Zepbound, also known as tirzepatide, as…
The findings showed that the obesity rate in the United States decreased from 46.2% in 2021 to 45.6%…
Sign in to your account